PT Suparma Tbk (ISX:SPMA) EBITDA: Rp176,460 Mil (TTM As of Mar. 2026)


ISX:SPMA PT Suparma Tbk ISX:SPMA
78 GF Score
Price Rp206.00
GF Value Rp239.19
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is PT Suparma Tbk EBITDA?

PT Suparma Tbk ISX:SPMA +0.98% 78 EBITDA is Rp176,460 Mil as of Mar. 2026. GuruFocus rates ISX:SPMA with a GF Score™ of 78/100 and a GF Value™ of Rp239.19 (Modestly Undervalued). The stock has 6 warning signs investors should review.

PT Suparma Tbk's EBITDA for the three months ended in Mar. 2026 was Rp21,180 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was Rp176,460 Mil.

During the past 12 months, the average EBITDA Growth Rate of PT Suparma Tbk was 6.30% per year. During the past 3 years, the average EBITDA Growth Rate was -26.60% per year. During the past 5 years, the average EBITDA Growth Rate was -11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 9 years, the highest 3-Year average EBITDA Growth Rate of PT Suparma Tbk was 36.10% per year. The lowest was -26.60% per year. And the median was 7.35% per year.

PT Suparma Tbk's EBITDA per Share for the three months ended in Mar. 2026 was Rp5.17. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp43.04.

During the past 12 months, the average EBITDA per Share Growth Rate of PT Suparma Tbk was 6.30% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -26.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 9 years, the highest 3-Year average EBITDA per Share Growth Rate of PT Suparma Tbk was 30.70% per year. The lowest was -26.60% per year. And the median was 7.35% per year.

PT Suparma Tbk  (ISX:SPMA) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


PT Suparma Tbk EBITDA Related Terms


PT Suparma Tbk EBITDA Historical Data

* Premium members only.

The historical data trend for PT Suparma Tbk's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Suparma Tbk EBITDA Chart

PT Suparma Tbk Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only 411,909.83 467,599.02 276,649.34 177,591.61 185,071.79

PT Suparma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29,791.81 59,963.51 33,633.48 61,682.99 21,180.05

ISX:SPMA vs SLVM: EBITDA Comparison

For the Paper & Paper Products subindustry, PT Suparma Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Suparma Tbk EV-to-EBITDA vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, PT Suparma Tbk's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT Suparma Tbk's EV-to-EBITDA falls into.


ISX:SPMA
78GF Score
PT Suparma Tbk ISX:SPMA
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PT Suparma Tbk's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

PT Suparma Tbk's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, PT Suparma Tbk's EBITDA was Rp185,072 Mil.

PT Suparma Tbk's EBITDA for the quarter that ended in Mar. 2026 is calculated as

PT Suparma Tbk's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, PT Suparma Tbk's EBITDA was Rp21,180 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp176,460 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of Rp176,460 Mil mean?
PT Suparma Tbk (ISX:SPMA) has a EBITDA of Rp176,460 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on PT Suparma Tbk.
Is PT Suparma Tbk's EBITDA too high?
PT Suparma Tbk's current EBITDA is Rp176,460 Mil. Overall, PT Suparma Tbk has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Suparma Tbk's EBITDA compare to SLVM?
PT Suparma Tbk's EBITDA of Rp176,460 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Forest Products company?
A good EBITDA depends on the Forest Products industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on PT Suparma Tbk. PT Suparma Tbk's current EBITDA is Rp176,460 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Suparma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Suparma Tbk (ISX:SPMA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp239.19, compared to a current price of Rp206.00 — trading 13.9% below its estimated fair value. The current EBITDA is Rp176,460 Mil. PT Suparma Tbk's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For PT Suparma Tbk (ISX:SPMA), the current EBITDA is Rp176,460 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Suparma Tbk (ISX:SPMA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Suparma Tbk stock appears to be undervalued. The current stock price of Rp206.00 is trading 13.9% below its estimated GF Value™ of Rp239.19. GuruFocus considers PT Suparma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:SPMA:

  • EBITDA: Rp176,460 Mil
  • GF Value™: Rp239.19 vs. price of Rp206.00 (13.9% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the ISX:SPMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Suparma Tbk Business Description

Address Jalan Raya Mastrip, No. 856 Warugunung, Karangpilang, East Java, Surabaya, IDN, 60221
PT Suparma Tbk is an Indonesia-based company that manufactures paper and paper products. The group manufactured paper and paper wrapping products for the industrial and consumer sectors. The firm offers Laminated Wrapping Kraft, Samson Kraft, MG Paper, Coated Duplex Board, Bathroom Tissue, Carrier Tissue, Industrial Roll Towel, Kitchen Towel, and Other products. Geographically, the firm generates the majority of its revenue from the local market.
78GF Score

Get the complete analysis for ISX:SPMA

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp206.00
Price
Rp239.19
GF Value